• 1
    Oreffo RO, Triffitt JT 1999 Future potentials for using osteogenic stem cells and biomaterials in orthopedics. Bone 25:5S9S.
  • 2
    Rose FR, Oreffo RO 2002 Bone tissue engineering: Hope vs hype. Biochem Biophys Res Commun 292:17.
  • 3
    Partridge K, Yang X, Clarke NM, Okubo Y, Bessho K, Sebald W, Howdle SM, Shakesheff KM, Oreffo RO 2002 Adenoviral BMP-2 gene transfer in mesenchymal stem cells: In vitro and in vivo bone formation on biodegradable polymer scaffolds. Biochem Biophys Res Commun 292:144152.
  • 4
    Langer R, Vacanti JP 1993 Tissue engineering. Science 260:920926.
  • 5
    Crane GM, Ishaug SL, Mikos AG 1995 Bone tissue engineering. Nat Med 1:13221324.
  • 6
    Putnam AJ, Mooney DJ 1996 Tissue engineering using synthetic extracellular matrices. Nat Med 2:824826.
  • 7
    Imai S, Kaksonen M, Raulo E, Kinnunen T, Fages C, Meng X, Lakso M, Rauvala H 1998 Osteoblast recruitment and bone formation enhanced by cell matrix-associated heparin-binding growth-associated molecule (HB-GAM). J Cell Biol 143:11131128.
  • 8
    Merenmies J, Rauvala H 1990 Molecular cloning of the 18-kDa growth-associated protein of developing brain. J Biol Chem 265:1672116724.
  • 9
    Hampton BS, Marshak DR, Burgess WH 1992 Structural and functional characterization of full-length heparin-binding growth associated molecule. Mol Biol Cell 3:8593.
  • 10
    Deuel TF, Zhang N, Yeh HJ, Silos-Santiago I, Wang ZY 2002 Pleiotrophin: A cytokine with diverse functions and a novel signaling pathway. Arch Biochem Biophys 397:162171.
  • 11
    Zhang N, Deuel TF 1999 Pleiotrophin and midkine, a family of mitogenic and angiogenic heparin-binding growth and differentiation factors. Curr Opin Hematol 6:4450.
  • 12
    Masuda H, Tsujimura A, Yoshioka M, Arai Y, Kuboki Y, Mukai T, Nakamura T, Tsuji H, Nakagawa M, Hashimoto-Gotoh T 1997 Bone mass loss due to estrogen deficiency is compensated in transgenic mice overexpressing human osteoblast stimulating factor-1. Biochem Biophys Res Commun 238:528533.
  • 13
    Tare RS, Rauvala H, Hashimoto-Gotoh T, Oreffo ROC, Clarke NMP, Roach HI 2001 The roles of the osteoblast stimulating factor-1 during endochondral ossification. J Bone Miner Res 16:1178.
  • 14
    Rauvala H, Vanhala A, Castren E, Nolo R, Raulo E, Merenmies J, Panula P 1994 Expression of HB-GAM (heparin-binding growth-associated molecules) in the pathways of developing axonal processes in vivo and neurite outgrowth in vitro induced by HB-GAM. Brain Res Dev Brain Res 79:157176.
  • 15
    Zhou HY, Ohnuma Y, Takita H, Fujisawa R, Mizuno M, Kuboki Y 1992 Effects of a bone lysine-rich 18 kDa protein on osteoblast-like MC3T3-E1 cells. Biochem Biophys Res Commun 186:12881293.
  • 16
    Friedenstein AJ 1976 Precursor cells of mechanocytes. Int Rev Cytol 47:327359.
  • 17
    Bianco P, Riminucci M, Gronthos S, Robey PG 2001 Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 19:180192.
  • 18
    Bianco P, Robey PG 2001 Stem cells in tissue engineering. Nature 414:118121.
  • 19
    Triffitt JT, Oreffo ROC 1998 Osteoblast lineage. In: ZaidiM (ed.) Advances in Organ Biology: Molecular and Cellular Biology of Bone, 1st ed., JAI Press Inc., London, UK, pp. 475498.
  • 20
    Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR 1999 Multilineage potential of adult human mesenchymal stem cells. Science 284:143147.
  • 21
    Owen M, Friedenstein AJ 1988 Stromal stem cells: Marrow-derived osteogenic precursors. Ciba Found Symp 136:4260.
  • 22
    Winn SR, Uludag H, Hollinger JO 1999 Carrier systems for bone morphogenetic proteins. Clin Orthop 367:S95S106.
  • 23
    Goshima J, Goldberg VM, Caplan AI 1991 The origin of bone formed in composite grafts of porous calcium phosphate ceramic loaded with marrow cells. Clin Orthop 269:274283.
  • 24
    Gundle R, Joyner CJ, Triffitt JT 1995 Human bone tissue formation in diffusion chamber culture in vivo by bone-derived cells and marrow stromal fibroblastic cells. Bone 16:597601.
  • 25
    Ishaug SL, Crane GM, Miller MJ, Yasko AW, Yaszemski MJ, Mikos AG 1997 Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res 36:1728.
  • 26
    Doll BA, Towle HJ, Hollinger JO, Reddi AH, Mellonig JT 1990 The osteogenic potential of two composite graft systems using osteogenin. J Periodontol 61:745750.
  • 27
    Ohgushi H, Goldberg VM, Caplan AI 1989 Heterotopic osteogenesis in porous ceramics induced by marrow cells. J Orthop Res 7:568578.
  • 28
    Yasko AW, Lane JM, Fellinger EJ, Rosen V, Wozney JM, Wang EA 1992 The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J Bone Joint Surg Am 74:659670.
  • 29
    Freed LE, Vunjak-Novakovic G, Biron RJ, Eagles DB, Lesnoy DC, Barlow SK, Langer R 1994 Biodegradable polymer scaffolds for tissue engineering. Biotechnology 12:689693.
  • 30
    Patel N, Padera R, Sanders GH, Cannizzaro SM, Davies MC, Langer R, Roberts CJ, Tendler SJ, Williams PM, Shakesheff KM 1998 Spatially controlled cell engineering on biodegradable polymer surfaces. FASEB J 12:14471454.
  • 31
    Peter SJ, Miller MJ, Yasko AW, Yaszemski MJ, Mikos AG 1998 Polymer concepts in tissue engineering. J Biomed Mater Res 43:422427.
  • 32
    Agrawal CM, Ray RB 2001 Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. J Biomed Mater Res 55:141150.
  • 33
    Ma PX, Zhang R, Xiao G, Franceschi R 2001 Engineering new bone tissue in vitro on highly porous poly(alpha-hydroxyl acids)/hydroxyapatite composite scaffolds. J Biomed Mater Res 54:284293.
  • 34
    Quirk RA, Chan WC, Davies MC, Tendler SJ, Shakesheff KM 2001 Poly(L-lysine)-GRGDS as a biomimetic surface modifier for poly(lactic acid). Biomaterials 22:865872.
  • 35
    Yang XB, Roach HI, Clarke NM, Howdle SM, Quirk R, Shakesheff KM, Oreffo RO 2001 Human osteoprogenitor growth and differentiation on synthetic biodegradable structures after surface modification. Bone 29:523531.
  • 36
    Howdle SM, Watson MS, Whitaker MJ, Popov MC, Davies MC, Mandel FS, Wang JD, Shakesheff KM 2001 Supercritical fluid mixing: Preparation of thermally sensitive polymer composites containing bioactive materials. Chem Commun 1:109110.
  • 37
    Whitaker MJ, Quirk RA, Howdle SM, Shakesheff KM 2001 Growth factor release from tissue engineering scaffolds. J Pharm Pharmacol 53:14271437.
  • 38
    Oreffo RO, Virdi AS, Triffitt JT 1997 Modulation of osteogenesis and adipogenesis by human serum in human bone marrow cultures. Eur J Cell Biol 74:251261.
  • 39
    Oreffo RO, Romberg S, Virdi AS, Joyner CJ, Berven S, Triffitt JT 1999 Effects of interferon alpha on human osteoprogenitor cell growth and differentiation in vitro. J Cell Biochem 74:372385.
  • 40
    Oreffo RO, Bord S, Triffitt JT 1998 Skeletal progenitor cells and ageing human populations. Clin Sci (Colch) 94:549555..
  • 41
    Rauvala H 1989 An 18-kd heparin-binding protein of developing brain that is distinct from fibroblast growth factors. EMBO J 8:29332941.
  • 42
    Sambrook J, Fritsch EF, Maniatis T 1989 Plasma vectors. In: SambrookJ, FritschEF, ManiatisT (eds.) Molecular Cloning—A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, New York, NY, USA, pp. 1410.
  • 43
    Wozney JM, Rosen V 1998 Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop 346:2637.
  • 44
    De Groot J 1998 Carriers that concentrate native bone morphogenetic protein in vivo. Tissue Eng 4:337341.
  • 45
    Milner PG, Shah D, Veile R, Donis-Keller H, Kumar BV 1992 Cloning, nucleotide sequence, and chromosome localization of the human pleiotrophin gene. Biochemistry 31:1202312028.
  • 46
    Li YS, Milner PG, Chauhan AK, Watson MA, Hoffman RM, Kodner CM, Milbrandt J, Deuel TF 1990 Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science 250:16901694.
  • 47
    Chauhan AK, Li YS, Deuel TF 1993 Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice. Proc Natl Acad Sci USA 90:679682.
  • 48
    Milner PG, Li YS, Hoffman RM, Kodner CM, Siegel NR, Deuel TF 1989 A novel 17 kD heparin-binding growth factor (HBGF-8) in bovine uterus: Purification and N-terminal amino acid sequence. Biochem Biophys Res Commun 165:10961103.
  • 49
    Kuo MD, Oda Y, Huang JS, Huang SS 1990 Amino acid sequence and characterization of a heparin-binding neurite-promoting factor (p18) from bovine brain. J Biol Chem 265:1874918752.
  • 50
    Raulo E, Julkunen I, Merenmies J, Pihlaskari R, Rauvala H 1992 Secretion and biological activities of heparin-binding growth-associated molecule. Neurite outgrowth-promoting and mitogenic actions of the recombinant and tissue-derived protein. J Biol Chem 267:1140811416.
  • 51
    Rauvala H, Peng HB 1997 HB-GAM (heparin-binding growth-associated molecule) and heparin-type glycans in the development and plasticity of neuron-target contacts. Prog Neurobiol 52:127144.
  • 52
    Brekke JH, Toth JM 1998 Principles of tissue engineering applied to programmable osteogenesis. J Biomed Mater Res 43:380398.
  • 53
    Mori M, Isobe M, Yamazaki Y, Ishihara K, Nakabayashi N 2000 Restoration of segmental bone defects in rabbit radius by biodegradable capsules containing recombinant human bone morphogenetic protein-2. J Biomed Mater Res 50:191198.